SUNNYVALE, Calif.--(BUSINESS WIRE)-- ("AOS") (Nasdaq: AOSL) today announced that the company will release its financial results for the fiscal second quarter ended December 31, 2024 on Wednesday, ...
Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced its planned design of the ...
BETHESDA, Md. & EVANSTON, Ill.--(BUSINESS WIRE)--Rotunda Capital Partners (“Rotunda”) has invested in Value Added Distributors, LLC (“VAD” or “the Company ...